Gregory P. Licholai

Greg Licholai teaches at Yale School of Management and is Co-Director of the Center for Digital Health. He teaches Innovating Health Care at Harvard Business School. He is Chief Medical and Innovation Officer at ICON plc. Previously, he was President of rare disease at Moderna Therapeutics, President and Chief Medical Officer at Castle Creek Pharmaceuticals and was a partner at McKinsey & Co. where he ran the healthcare data service line. He was an executive at Proteostasis, Amicus Therapeutics and Medtronic Neurological as well as venture investor for Domain Associates. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University and Boston College. He trained in Neurosurgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals of Harvard Medical School. He serves on multiple boards including the Digital Medicine Society (DiMe) and advisor on the Clinical Trials Transformation Initiative (CTTI), a partnership founded by Duke University and the Food and Drug Administration (FDA). He writes about innovation for Forbes.